| RS2078113517 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2078116884 |
MTHFD1
|
Health Risk |
Likely pathogenic |
— |
| RS2078117088 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2078118670 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2078126852 |
MTHFD1
|
Health Risk |
Pathogenic |
— |
| RS2078133150 |
CTNNB1
|
Health Risk |
Pathogenic |
Conspicuously happy disposition, Conspicuously happy disposition |
| RS2078136352 |
NTRK2
|
Health Risk |
Likely pathogenic |
Obesity, hyperphagia |
| RS2078140157 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078141257 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078141730 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078146524 |
MTHFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia |
| RS2078151590 |
CTNNB1;LOC126806658
|
Health Risk |
Pathogenic |
— |
| RS2078151677 |
CTNNB1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2078159857 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078159952 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078160204 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078160286 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078160335 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078161525 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078162308 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078164049 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS2078172984 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS2078196892 |
CTNNB1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2078198486 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078201673 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Colorectal cancer |
| RS2078260891 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2078261207 |
TRMU
|
Health Risk |
Pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2078291953 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078297140 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS2078297932 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS2078356915 |
CTNNB1
|
Health Risk |
Likely pathogenic |
CTNNB1-related syndromic intellectual disability, CTNNB1-related syndromic intellectual disability |
| RS2078362215 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078362331 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Colorectal cancer, Colorectal cancer |
| RS2078362860 |
CTNNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2078376803 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2078377046 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2078377150 |
CTNNB1;LOC126806659
|
Health Risk |
Likely pathogenic |
— |
| RS2078377820 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078387202 |
KANSL1
|
Health Risk |
Likely pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2078389049 |
KANSL1
|
Health Risk |
Pathogenic |
Chromatinopathy, Chromatinopathy |
| RS2078408746 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078415221 |
COL6A2
|
Health Risk |
Pathogenic |
— |
| RS2078415602 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078419667 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078432433 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2078435023 |
CTNNB1
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 7, Exudative vitreoretinopathy 7 |
| RS2078435846 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078436466 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2078438031 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2078438903 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078439012 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078441559 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2078449522 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS2078453451 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2078462673 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078477419 |
COL6A2
|
Health Risk |
Pathogenic |
COL6A2-related disorder, Bethlem myopathy 1A |
| RS2078477786 |
COL6A2
|
Health Risk |
Pathogenic |
Proximal muscle weakness, Bethlem myopathy 1A |
| RS2078478648 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078486744 |
SP110
|
Health Risk |
Pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Hepatic veno-occlusive disease-immunodeficiency syndrome |
| RS2078489585 |
COL6A2
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS2078499771 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078499825 |
COL6A2
|
Health Risk |
Likely pathogenic |
Collagen 6-related myopathy, Collagen 6-related myopathy |
| RS2078511375 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2078512215 |
PRICKLE2
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2078513383 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS2078513943 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS2078514224 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS2078521344 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078522713 |
KDM6B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Malignant tumor of urinary bladder |
| RS2078522740 |
KDM6B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2078532687 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078533830 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS2078539742 |
KDM6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2078556781 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078575287 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2078576503 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078587931 |
KDM6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2078612090 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078638223 |
KDM6B
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2078645664 |
TLK2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078651031 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078657536 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1B |
| RS2078661471 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS2078662535 |
COL6A2
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS2078690809 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078691261 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078697392 |
KDM6B;LOC121587574
|
Health Risk |
Pathogenic |
— |
| RS2078700148 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2078705936 |
KDM6B
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities |
| RS2078720428 |
TRANK1
|
Health Risk |
association |
Autism spectrum disorder, Autism spectrum disorder |
| RS2078745026 |
BRIP1
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2078746295 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2078747114 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2078758552 |
CNNM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2078758805 |
CNNM4
|
Health Risk |
Pathogenic |
— |
| RS2078763986 |
CNNM4
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2078764558 |
CNNM4
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2078772292 |
CNNM4
|
Health Risk |
Pathogenic |
— |
| RS2078778379 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2078779429 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |